Skip to main content
Oladimeji Akinboro, MD, Internal Medicine, Boston, MA

Oladimeji Akinboro MD

Hematology/Oncology


Hematology/Oncology Fellow

Join to View Full Profile
  • Boston Medical CenterSection of Hematology/Oncology, FGH Building, 1st FloorBoston, MA 02118

Dr. Akinboro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Boston University Medical Center
    Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Chief Residency, Internal Medicine, 2016 - 2017
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2013 - 2016
  • University of Ilorin Faculty of Health Sciences
    University of Ilorin Faculty of Health SciencesClass of 2006

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2017 - 2026
  • MA State Medical License
    MA State Medical License 2017 - 2020
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Contemporary patterns of racial/ethnic disparities in surgical treatment and overall survival for localized resectable non-small cell lung cancer in the United States. 
    2019 ASCO Annual Meeting - 6/1/2019
  • E-cigarette use among patients of smoking-related cancers in the United States. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Adding Chemotherapy to Immunotherapy Improves Survival in Advanced Non-Small Cell Lung Cancer
    Adding Chemotherapy to Immunotherapy Improves Survival in Advanced Non-Small Cell Lung CancerJune 5th, 2021
  • Secondhand Smoke Exposure in Cancer Survivors Remains High
    Secondhand Smoke Exposure in Cancer Survivors Remains HighSeptember 10th, 2017
  • Secondhand Smoke Exposure in Cancer Survivors Remains High
    Secondhand Smoke Exposure in Cancer Survivors Remains HighSeptember 10th, 2017

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: